All patients deserve access to the right testing & treatment at the right time

From Testing to Targeted Treatment Program (FT3) is a non-profit multi-stakeholder collaborative program that aims to unify, accelerate and build on existing efforts to make precision medicine a reality for all patients who could benefit from it. Co-led by patients, FT3 is strongly focused on patient needs and experiences.

Discover the Story of Precision Medicine

A resource for all stakeholders in the Precision Medicine space to learn more about Precision Medicine, what it is, its history and application in real-life, including patient experiences and stories.

Program highlights

The Story of Precision Medicine

A resource for all stakeholders in the Precision Medicine space to learn more about Precision Medicine, what it is, its history and application in real-life, including patient experiences and stories..

 

Program update – June 2023

Here is an update on the latest developments and news in FT3. Please help us by sharing this update with your network, and thank you for your continued support in helping us make precision medicine a more accessible reality for patients!

As the FT3 Country Pilots continue to advance, on behalf of the local steering groups I’m pleased to provide you with an update on the ongoing pilots in Spain and Hungary.

The @LUNGevity International Lung Cancer Survivorship Conference brings some of the world's leading lung cancer experts to discuss various advances in the diagnosis & treatment of the disease,
➡️Sign up now to reserve your spot at http://lungevity.org/ilcsc #lungcancer #lcsm

#CountryPilot
As part of their preparatory work, our partners from Hungary have used an “access barrier cause-effect canvas”, which you can download and use in your work here: https://eu1.hubs.ly/H04S_sx0

Load More

About us

Our motivation

All patients deserve access to the right testing & treatment at the right time. While Precision Medicine (PM) can transform lives, its potential benefits have not yet been fully realized.

Our ambition

Our goal is to improve access to precision medicine for all patients who could benefit from it, by generating better evidence, creating awareness and building the conditions for better access, starting with testing and cancer.

The partnership

We are an independent, nonprofit, global and multistakeholder consortium, building solutions with patients, for patients. Its members and community include individual patients, patient organizations, pharmaceutical & diagnostics companies, healthcare professionals and medical societies, payers, HTA bodies and regulators.

Keep up to date with developments from the precision medicine ecosystem

We don’t spam. Just key info at the right time.